WO2010120133A2 - Composition phytoestrogène utilisée pour prévenir les symptômes climatériques ou ménopausiques - Google Patents

Composition phytoestrogène utilisée pour prévenir les symptômes climatériques ou ménopausiques Download PDF

Info

Publication number
WO2010120133A2
WO2010120133A2 PCT/KR2010/002349 KR2010002349W WO2010120133A2 WO 2010120133 A2 WO2010120133 A2 WO 2010120133A2 KR 2010002349 W KR2010002349 W KR 2010002349W WO 2010120133 A2 WO2010120133 A2 WO 2010120133A2
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
composition
present
preventing
relieving
Prior art date
Application number
PCT/KR2010/002349
Other languages
English (en)
Korean (ko)
Other versions
WO2010120133A3 (fr
Inventor
김재수
곽보연
이권택
이재경
Original Assignee
(주)내츄럴엔도텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)내츄럴엔도텍 filed Critical (주)내츄럴엔도텍
Publication of WO2010120133A2 publication Critical patent/WO2010120133A2/fr
Publication of WO2010120133A3 publication Critical patent/WO2010120133A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234—Cnidium (snowparsley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967—Lilium, e.g. tiger lily or Easter lily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne une composition phytoestrogène utilisée pour prévenir les symptômes climatériques ou ménopausiques ou y remédier. Ladite composition phytoestrogène comprend au moins un extrait sélectionné dans le groupe comprenant comme principe actif des extraits de lis, de Cnidium monnieri (L.) Cusson, de Polygala tenuiflora et de racines de mûre blanche. Ce principe actif présente l'activité de phytoestrogènes sains par des effets antagonistes et agonistes des oestrogènes, permettant ainsi de traiter ou de prévenir différents symptômes dus au manque d'oestrogènes pendant le climatère ou la ménopause et agit comme un antagoniste des oestrogènes et les problèmes induits par les traitements hormonaux de substitution connus semblent de ce fait évités. Le principe actif de la présente invention ne produit en outre pratiquement pas d'effets secondaires au niveau du corps humain étant donné que ledit principe actif est une substance naturelle utilisée de longue date comme médicament et qu'il peut être préparé comme composition pharmaceutique, comme composition nutraceutique ou comme composition alimentaire.
PCT/KR2010/002349 2009-04-15 2010-04-15 Composition phytoestrogène utilisée pour prévenir les symptômes climatériques ou ménopausiques WO2010120133A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0032821 2009-04-15
KR1020090032821A KR101087608B1 (ko) 2009-04-15 2009-04-15 갱년기 또는 폐경기 증상의 예방 또는 완화용 식물성에스트로겐 조성물

Publications (2)

Publication Number Publication Date
WO2010120133A2 true WO2010120133A2 (fr) 2010-10-21
WO2010120133A3 WO2010120133A3 (fr) 2011-03-03

Family

ID=42983012

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/002349 WO2010120133A2 (fr) 2009-04-15 2010-04-15 Composition phytoestrogène utilisée pour prévenir les symptômes climatériques ou ménopausiques

Country Status (2)

Country Link
KR (1) KR101087608B1 (fr)
WO (1) WO2010120133A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101683344B1 (ko) 2014-10-27 2016-12-07 숙명여자대학교산학협력단 카르노식산을 유효성분으로 포함하는 갱년기 증상의 예방 또는 개선용 조성물
KR101832897B1 (ko) 2015-05-26 2018-02-27 (주)뉴트리 모루신, 구와논 지 또는 상백피를 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
KR20160013227A (ko) 2016-01-14 2016-02-03 김득수 녹용차 제조방법
KR20180098459A (ko) * 2017-02-24 2018-09-04 한국 한의학 연구원 백합 비늘줄기 추출물을 포함하는 인지장애의 예방 또는 치료용 약학 조성물
KR102075836B1 (ko) 2018-05-31 2020-02-10 숙명여자대학교산학협력단 마키베리 추출물, 당귀 추출물 및 시계꽃 추출물을 유효성분으로 함유하는 갱년기 증상 예방 또는 치료용 조성물
KR20240107861A (ko) 2022-12-30 2024-07-09 박주현 밀기울 추출물을 유효성분으로 함유하는 여성 갱년기 증상의 예방 및 치료용 약학적 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005343872A (ja) * 2004-06-07 2005-12-15 Kao Corp アロマターゼ活性化剤
WO2006065608A2 (fr) * 2004-12-17 2006-06-22 Bionovo, Inc. Extraits oestrogeniques de morus alba et utilisations de ceux-ci

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005343872A (ja) * 2004-06-07 2005-12-15 Kao Corp アロマターゼ活性化剤
WO2006065608A2 (fr) * 2004-12-17 2006-06-22 Bionovo, Inc. Extraits oestrogeniques de morus alba et utilisations de ceux-ci

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHOI, SUN-YOUNG ET AL JOURNAL OF KOREAN SOCIETY OF FOOD SCIENCE AND TECHNOLOGY vol. 37, no. 4, 2005, pages 549 - 556 *
LIU, J.-X. ET AL CHINESE JOURNAL OF CLINICAL REHABILITATION vol. 9, no. 23, 2005, pages 186 - 189 *

Also Published As

Publication number Publication date
KR101087608B1 (ko) 2011-11-29
KR20100114333A (ko) 2010-10-25
WO2010120133A3 (fr) 2011-03-03

Similar Documents

Publication Publication Date Title
WO2010120133A3 (fr) Composition phytoestrogène utilisée pour prévenir les symptômes climatériques ou ménopausiques
Vikash et al. Piper betel Phytochemistry, traditional use & pharmacological activity a review
Shirwaikar et al. Medicinal plants for the management of post menopausal osteoporosis: A review
NZ594022A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
MY160000A (en) Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin ii antagonist and/or diuretic
WO2015120110A3 (fr) Nouvelles formulations pharmaceutiques
CL2015001975A1 (es) (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
MX336861B (es) Formulacion de farmaco resistente al abuso.
WO2008116890A3 (fr) Nouvelles compositions pharmaceutiques
WO2006096434A3 (fr) Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l'anxiete
WO2011002223A3 (fr) Composition pour favoriser la différenciation adipocytaire constituée d'un extrait de rehmannia glutinosa, de réglisse, de graine de coix lacryma-jobi, de germe de blé, de fruit de chaenomeles sinensis, d'ecorce d'acanthopanacis ou de radix puerariae
WO2011043631A3 (fr) Composition pharmaceutique pour la prévention et le traitement du rhume, contenant un extrait de reynoutria elliptica, une fraction de celui-ci ou un composé à base de stilbène
WO2009026473A3 (fr) Compositions et formulations thérapeutiques stabilisées
WO2011159100A2 (fr) Composition pharmaceutique anticancéreuse
WO2011059292A3 (fr) Concentré ou extrait de pousse d'aloès officinal favorisant fortement la croissance des cellules cutanées et présentant des effets anti-allergiques et antioxydants supérieurs
Bakhsh et al. Catechin-rich oil palm leaf extract enhances bone calcium content of estrogen-deficient rats
WO2005065639A3 (fr) Nouvelles compositions pharmaceutiques
ES2325291A1 (es) "uso de un extracto de silybum marianum"
WO2011052935A3 (fr) Composition destinée à réduire la glycémie, contenant un extrait de smilax china l., de momordica charantia et de cordyceps militaris comme principe actif
Sangi et al. Hepatoprotective effects of oleuropein, thymoquinone and fruit of phoenix dactylifera on CCl 4 induced hepatotoxicity in rats
CA2756742A1 (fr) Composition pour la prevention ou le traitement de l'insomnie
WO2010008150A3 (fr) Composition pour prévenir ou traiter l'ostéoporose qui contient comme principe actif un mélange d'extraits de saururus chinensis et de scutellaria baicalensis
WO2008125771A3 (fr) Utilisation cosmetique d'un extrait de debaryomyces hansenii
WO2008120542A1 (fr) Composition alimentaire ayant la forme d'une préparation solide comprenant la plante polygonum aviculare en tant que principe actif
WO2012048446A8 (fr) Nouvel usage d'ingrédients chimiques dans le cynomorium comme phytoestrogène

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10764672

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10764672

Country of ref document: EP

Kind code of ref document: A2